Our study, on the other hand, unraveled and validated that ZFX, a key C2H2-type, ZNF family transcription factor, mediates UGCG expression and thereby modulates sphingolipid and ganglioside metabolism and tumor progression. The gene discussed is ZFX; the disease is neoplasm.